4DMedical (ASX:4DX) EBITDA Margin % : -1,770.24% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. 4DMedical's EBITDA for the six months ended in Dec. 2023 was A$-14.04 Mil. 4DMedical's Revenue for the six months ended in Dec. 2023 was A$0.79 Mil. Therefore, 4DMedical's EBITDA margin for the quarter that ended in Dec. 2023 was -1,770.24%.

4DMedical EBITDA Margin % Historical Data

The historical data trend for 4DMedical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical EBITDA Margin % Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

EBITDA Margin %

-8,311.52

-3,344.88

-10,129.43

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial			-10,532.48	-2,084.52	-3,089.51	6,641.67	-1,770.24

Competitive Comparison of 4DMedical's EBITDA Margin %

For the Medical Devices subindustry, 4DMedical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4DMedical's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where 4DMedical's EBITDA Margin % falls into.

4DMedical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

4DMedical's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-28.565	/	0.282
	=	-10,129.43 %

4DMedical's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-14.038	/	0.793
	=	-1,770.24 %

4DMedical (ASX:4DX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

4DMedical EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of 4DMedical's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines